Suchergebnisse - "Keskinkılıc, Merve"

PubPharm (27)

1

Antibody-Drug Conjugates in Triple Negative Breast Cancer

enthalten in: Clinical breast cancer | 2024

von Keskinkilic, M. | Sacks, R.

2

Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy : a Turkish Oncology Group (TOG) study

enthalten in: Journal of chemotherapy (Florence, Italy) | 2024

von Yildirim, H. | Kapar, C. | Koksal, B. | +46

3

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients : a Turkish oncology group (TOG) study

enthalten in: International journal of clinical oncology | 2024

von Yıldırım, H. | Kutlu, Y. | Mutlu, E. | +31

4

The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024

von Gultekin, S. | Cakir, A. | Guc, Z. | +5

5

Triple Negative Breast Cancers : An Obsolete Entity?

enthalten in: Clinical breast cancer | 2024

von Keskinkılıc, M. | Gökmen-Polar, Y. | Badve, S.

6

CDK4/6 Inhibition in the Metastatic Setting : Where Are We Headed?

enthalten in: Current treatment options in oncology | 2023

von Sakach, E. | Keskinkilic, M. | Wood, S. | +2

7

The Prognostic Nutritional Index (PNI) : A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma

enthalten in: Journal of clinical medicine | 2023

von Ellez, H. | Keskinkilic, M. | Semiz, H. | +3

8

The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy : A multicentric retrospective study

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Caliskan Yildirim, E. | Atag, E. | Coban, E. | +8

9

The role of immune checkpoint inhibition in triple negative breast cancer

enthalten in: Expert review of anticancer therapy | 2023

von Tarekegn, K. | Keskinkilic, M. | Kristoff, T. | +2

10

The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer : is it a novel factor for stratification? (Turkish Oncology Group Study)

enthalten in: Journal of cancer research and clinical oncology | 2023

von Hizal, M. | Bilgin, B. | Paksoy, N. | +35